Related Experiment Video
Updated: Jul 7, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Review article: RNA interference--potential therapeutic applications for the gastroenterologist
R S Pellish1, A Nasir, B Ramratnam
1Division of Gastroenterology, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA.
RNA interference (RNAi) offers a new way to control gene expression for treating gastrointestinal and liver diseases. Further research into delivery and side effects is needed for clinical use.
Area of Science:
- Molecular Biology
- Genetics
- Gastroenterology
Background:
- RNA interference (RNAi) is a gene regulation technique using short double-stranded RNA.
- RNAi selectively inhibits gene expression post-transcriptionally.
- Gastrointestinal and hepatic disorders are promising targets for RNAi therapy due to drug delivery advantages.
Purpose of the Study:
- To review literature on RNAi applications in gastroenterology.
- To explore future RNAi-based therapies for luminal diseases.
Main Methods:
- Literature search using PubMed with the term 'RNA interference'.
- Focus on studies related to therapeutic uses in gastrointestinal and liver diseases.
Main Results:
- Cellular and animal models show potential for short-interfering RNA (siRNA) in treating viral hepatitis and inflammatory bowel disease.
- siRNA-based therapies may offer a new frontier in molecular-targeted treatments for gastroenterology and hepatology.
Conclusions:
- Short-interfering RNA (siRNA) enables specific gene expression inhibition.
- Clinical translation requires further investigation of side effects and delivery systems.
- Mucosal or endoscopic delivery of siRNA may lead to early clinical applications.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics

